Page 72 - JCTR-11-5

Journal of Clinical and
Translational Research Metabolism of healthy and leukemic stem cells

101. Garcia D, Shaw RJ. AMPK: Mechanisms of cellular energy glycolysis by Pdk functions as a metabolic checkpoint for
sensing and restoration of metabolic balance. Mol Cell. cell cycle quiescence in hematopoietic stem cells. Cell Stem
2017;66(6):789-800. Cell. 2013;12(1):49-61.
doi: 10.1016/j.molcel.2017.05.032 doi: 10.1016/j.stem.2012.10.011
102. Torrence ME, MacArthur MR, Hosios AM, et al. The 112. Testa U, Labbaye C, Castelli G, Pelosi E. Oxidative stress and
mTORC1-mediated activation of ATF4 promotes protein hypoxia in normal and leukemic stem cells. Exp Hematol.
and glutathione synthesis downstream of growth signals. 2016;44(7):540-560.
Elife. 2021;10:e63326.
doi: 10.1016/j.exphem.2016.04.012
doi: 10.7554/eLife.63326
113. Velasco-Hernandez T, Soneji S, Hidalgo I, Erlandsson E,
103. Ben-Sahra I, Hoxhaj G, Ricoult SJH, Asara JM, Cammenga J, Bryder D. Hif-1α deletion may lead to adverse
Manning BD. mTORC1 induces purine synthesis through treatment effect in a mouse model of MLL-AF9-driven
control of the mitochondrial tetrahydrofolate cycle. Science. AML. Stem Cell Reports. 2019;12(1):112-121.
2016;351(6274):728-733.
doi: 10.1016/j.stemcr.2018.11.023
doi: 10.1126/science.aad0489
114. Qiu S, Cai Y, Wang Z, Xie Y, Zhang A. Decoding functional
104. Hardie DG. AMPK--sensing energy while talking to other significance of small molecule metabolites. Biomed
signaling pathways. Cell Metab. 2014;20(6):939-952. Pharmacother. 2023;158:114188.
doi: 10.1016/j.cmet.2014.09.013 doi: 10.1016/j.biopha.2022.114188
105. Krastinaite I, Charkavliuk S, Navakauskiene R, 115. Cajka T, Fiehn O. Toward merging untargeted and targeted
Borutinskaite VV. Metformin as an enhancer for the methods in mass spectrometry-based metabolomics and
treatment of chemoresistant CD34+ acute myeloid leukemia lipidomics. Anal Chem. 2016;88(1):524-545.
cells. Genes (Basel). 2024;15(5):648.
doi: 10.1021/acs.analchem.5b04491
doi: 10.3390/genes15050648
116. Roberts LD, Souza AL, Gerszten RE, Clish CB. Targeted
106. Bao B, Wang Z, Ali S, et al. Metformin inhibits cell metabolomics. Curr Protoc Mol Biol. 2012;98:30.2.1-30.2.24.
proliferation, migration and invasion by attenuating CSC
function mediated by deregulating miRNAs in pancreatic doi: 10.1002/0471142727.mb3002s98
cancer cells. Cancer Prev Res (Phila). 2012;5(3):355-364. 117. Greving MP, Patti GJ, Siuzdak G. Nanostructure-initiator
doi: 10.1158/1940-6207.Capr-11-0299 mass spectrometry metabolite analysis and imaging. Anal
Chem. 2011;83(1):2-7.
107. Farge T, Saland E, De Toni F, et al. Chemotherapy-resistant
human acute myeloid leukemia cells are not enriched for doi: 10.1021/ac101565f
leukemic stem cells but require oxidative metabolism. 118. Niehaus M, Soltwisch J, Belov ME, Dreisewerd K.
Cancer Discov. 2017;7(7):716-735. Transmission-mode MALDI-2 mass spectrometry imaging
doi: 10.1158/2159-8290.CD-16-0441 of cells and tissues at subcellular resolution. Nat Methods.
2019;16(9):925-931.
108. De Jonge-Peeters SD, Kuipers F, De Vries EG, Vellenga E.
ABC transporter expression in hematopoietic stem cells and doi: 10.1038/s41592-019-0536-2
the role in AML drug resistance. Crit Rev Oncol Hematol. 119. Molenaar MR, Shahraz M, Delafiori J, et al. Increasing
2007;62(3):214-226. quantitation in spatial single-cell metabolomics by
doi: 10.1016/j.critrevonc.2007.02.003 using fluorescence as ground truth. Front Mol Biosci.
2022;9:1021889.
109. Porro A, Iraci N, Soverini S, et al. c-MYC oncoprotein
dictates transcriptional profiles of ATP-binding cassette doi: 10.3389/fmolb.2022.1021889
transporter genes in chronic myelogenous leukemia 120. Schmidt CA, Fisher-Wellman KH, Neufer PD. From
CD34+ hematopoietic progenitor cells. Mol Cancer Res. OCR and ECAR to energy: Perspectives on the design
2011;9(8):1054-1066. and interpretation of bioenergetics studies. J Biol Chem.
doi: 10.1158/1541-7786.MCR-10-0510 2021;297(4):101140.
110. Rozovski U, Hazan-Halevy I, Barzilai M, Keating MJ, doi: 10.1016/j.jbc.2021.101140
Estrov Z. Metabolism pathways in chronic lymphocytic 121. Chen L, Zhong F, Zhu J. Bridging targeted and untargeted
leukemia. Leuk Lymphoma. 2016;57(4):758-765. mass spectrometry-based metabolomics via hybrid
doi: 10.3109/10428194.2015.1106533 approaches. Metabolites. 2020;10(9):348.
111. Takubo K, Nagamatsu G, Kobayashi CI, et al. Regulation of doi: 10.3390/metabo10090348

Volume 11 Issue 5 (2025) 66 doi: 10.36922/JCTR025320053